The Journal of Practical Medicine >
Efficacy of autofluorescence point⁃spectral analysis combined with the immune colloidal gold technique for the detection of ectopic microscopic parathyroid glands to guide surgery for secondary hyperparathyroidism
Received date: 2024-06-26
Online published: 2024-11-05
Objective To evaluate the intraoperative identification of ectopic parathyroid tissue in the central neck region using autofluorescence point-spectral analysis (AFPSA) combined with immune colloidal gold technique (ICGT), for guiding total parathyroidectomy (TPTX) or clean parathyroidectomy (CPTX) in the management of secondary hyperparathyroidism (SHPT). Methods Retrospectively collected and compared the clinical data of 64 patients with SHPT from October 2019 to June 2023. In the observation group, TPTX was performed as the initial procedure in 36 cases, followed by sampling of suspicious targets using AFPSA in the central neck area and subsequent detection through ICGT. CPTX was then conducted if a positive result was obtained. On the other hand, the control group consisted of 28 cases where only TPTX was performed without any additional tests during surgery. The surgical data, parathyroid hormone (PTH) levels, blood calcium levels, blood phosphorus levels, alkaline phosphatase (ALP) levels, regression of clinical symptoms, changes in parathyroid function and occurrence of hypocalcemia were compared between these two groups. Results In the observation group, there were 9 cases of AFPSA-ICGT positivity, including 2 left-sided cases, 4 right-sided cases, and 3 thymic cases; among these positive cases, there were a total of 10 locations with mildly hyperplastic or nonhyperplastic microscopic parathyroid tissue. The difference in the number of total parathyroid glands removed (including ectopic) between the two groups was statistically significant (P < 0.05). At both 3 and 6 months postoperatively, ALP levels in the observation group were significantly lower than those in the control group (P < 0.01 and P < 0.001 respectively); at 6 months postoperatively, differences in PTH and blood phosphorus levels between the two groups were also statistically significant (P < 0.05 and P < 0.001 respectively). Joint bone pain and skin itching recurred in some patients within the control group at six months after surgery (P < 0.05), whereas recurrence of SHPT was less frequent within the observation group compared to controls (P < 0.05); however, no statistically significant differences were observed regarding postoperative hypoparathyroidism or hyperparathyroidism as well as hypocalcemia between either groups. Conclusion The AFPSA-ICGT intraoperative test can be utilized to guide surgery for SHPT, enabling accurate and efficient identification as well as safe targeting of parathyroid tissues that may not exhibit obvious hyperplasia in the central cervical region.
Kun PENG , Baozhong YAO , Hongcun CHEN , Jun ZHANG , Wenzhong BAO , Wenbo LI , Weitao SONG , Sailong SANG , Li LIN , Zhixing JIA , Liang LI . Efficacy of autofluorescence point⁃spectral analysis combined with the immune colloidal gold technique for the detection of ectopic microscopic parathyroid glands to guide surgery for secondary hyperparathyroidism[J]. The Journal of Practical Medicine, 2024 , 40(20) : 2905 -2912 . DOI: 10.3969/j.issn.1006-5725.2024.20.014
| 1 | van der PLAS W Y, NOLTES M E, van GINHOVEN T M, et al. Secondary and tertiary hyperparathyroidism: A narrative review[J]. Scand J Surg, 2020,109(4): 271-278. doi:10.1177/1457496919866015 |
| 2 | 叶明君, 戴勇, 汤冬娥, 等. 腹膜透析代谢组学研究进展[J]. 实用医学杂志, 2022,38(1): 1-6. doi:10.3969/j.issn.1006-5725.2022.01.001 |
| 3 | DREAM S, KUO L E, KUO J H, et al. The American association of endocrine surgeons guidelines for the definitive surgical management of secondary and tertiary renal hyperparathyroidism[J]. Ann Surg, 2022,276(3): e141-e176. doi:10.1097/sla.0000000000005522 |
| 4 | 徐骏, 王笑薇, 刘旻, 等. 碳酸镧联合西那卡塞、骨化三醇对血液透析伴继发性甲状旁腺功能亢进症的疗效[J]. 实用医学杂志, 2021,37(1): 82-86. |
| 5 | ZHU L, CHENG F, ZHU X, et al. Safety and effectiveness of reoperation for persistent or recurrent drug refractory secondary hyperparathyroidism[J]. Gland Surg, 2020,9(2): 401-408. doi:10.21037/gs-20-391 |
| 6 | KOMABA H, HAMANO T, FUJII N, et al. Parathyroidectomy vs cinacalcet among patients undergoing hemodialysis[J]. J Clin Endocrinol Metab, 2022,107(7): 2016-2025. doi:10.1210/clinem/dgac142 |
| 7 | BALI P, TOUSSAINT N D, TIONG M K, et al. Outcomes following parathyroidectomy for secondary hyperparathyroidism in patients with chronic kidney disease: a single-centre study[J]. Intern Med J, 2022,52(12): 2107-2115. doi:10.1111/imj.15467 |
| 8 | TATERRA D, WONG L M, VIKSE J, et al. The prevalence and anatomy of parathyroid glands: a meta-analysis with implications for parathyroid surgery[J]. Langenbecks Arch Surg, 2019,404(1): 63-70. doi:10.1007/s00423-019-01751-8 |
| 9 | 韦树建, 郑桂彬, 刘洋, 等. 甲状旁腺自体荧光在甲状腺癌根治手术中的临床应用[J]. 中国耳鼻咽喉头颈外科, 2020,27(8): 446-450. |
| 10 | 潘新民, 严霞, 杨屹立, 等. 甲状腺外科手术中甲状旁腺识别技术研究进展[J]. 中国普通外科杂志, 2023,32(11): 1787-1796. |
| 11 | 中国医师协会外科医师分会甲状腺外科医师委员会, 中国研究型医院学会甲状腺疾病专业委员会. 慢性肾脏病继发甲状旁腺功能亢进外科临床实践中国专家共识(2021版)[J]. 中国实用外科杂志, 2021,41(8): 841-848. |
| 12 | 殷照才, 赵晚君, 盛勇, 等. 影响继发性甲状旁腺功能亢进手术疗效相关因素分析[J]. 中国实用外科杂志, 2018,38(6): 650-653. |
| 13 | 郑洵, 卢春燕, 周莉, 等. 继发性甲状旁腺功能亢进围手术期多学科综合诊治华西共识[J]. 中国普外基础与临床杂志, 2023,30(2): 129-136. |
| 14 | 徐金梅, 林晶晶, 陈思瑜, 等. 术中甲状旁腺激素测定对继发性甲状旁腺功能亢进患者手术疗效的预测价值[J]. 肾脏病与透析肾移植杂志, 2020,29(6): 514-519. |
| 15 | JAIN N, REILLY R F. Hungry bone syndrome[J]. Curr Opin Nephrol Hypertens, 2017,26(4): 250-255. doi:10.1097/mnh.0000000000000327 |
| 16 | BITAR Z I, HAJJIAH A M, MAADARANI O S, et al. Hypocalcemia in patients with osteoporosis and normal renal function, treated with denosumab, a retrospective analysis[J]. Nutr Metab Insights, 2024,17: 1538586932. doi:10.1177/11786388231223604 |
| 17 | TOMINAGA Y, MATSUOKA S, UNO N, et al. Removal of autografted parathyroid tissue for recurrent renal hyperparathyroidism in hemodialysis patients[J]. World J Surg, 2010,34(6): 1312-1317. doi:10.1007/s00268-010-0412-9 |
| 18 | 佘键涛, 夏发达, 戴斌, 等. 2022版 美国内分泌外科医师协会《继发性及三发性甲状旁腺功能亢进症确定性外科治疗指南》外科部分解读[J]. 中国普通外科杂志, 2022,31(11): 1405-1413. |
| 19 | NOUSSIOS G, ANAGNOSTIS P, NATSIS K. Ectopic parathyroid glands and their anatomical, clinical and surgical implications[J]. Exp Clin Endocrinol Diabetes, 2012,120(10): 604-610. doi:10.1055/s-0032-1327628 |
| 20 | LOPINTO M, RUBIO G A, KHAN Z F, et al. Location of abnormal parathyroid glands: lessons from 810 parathyroidectomies[J]. J Surg Res, 2017,207: 22-26. doi:10.1016/j.jss.2016.08.045 |
| 21 | HOJAIJ F, VANDERLEI F, PLOPPER C, et al. Parathyroid gland anatomical distribution and relation to anthropometric and demographic parameters: a cadaveric study[J]. Anat Sci Int, 2011,86(4): 204-212. doi:10.1007/s12565-011-0111-0 |
| 22 | PATTOU F N, PELLISSIER L C, NOEL C, et al. Supernumerary parathyroid glands: frequency and surgical significance in treatment of renal hyperparathyroidism[J]. World J Surg, 2000,24(11): 1330-1334. doi:10.1007/s002680010220 |
| 23 | OKADA M, TOMINAGA Y, YAMAMOTO T, et al. Location frequency of missed parathyroid glands after parathyroidectomy in patients with persistent or recurrent secondary hyperparathyroidism[J]. World J Surg, 2016,40(3): 595-599. doi:10.1007/s00268-015-3312-1 |
| 24 | 彭钰蓓, 叶梦醒, 马可欣, 等. 甲状旁腺功能亢进症术前和术中定位病变甲状旁腺的研究进展[J]. 中国普通外科杂志, 2022,31(11): 1518-1526. |
| 25 | 刘德军, 冯彦林, 余丰文, 等. 99m锝-甲氧基异丁基异腈SPECT/CT显像对慢性肾病继发甲状旁腺功能亢进甲状旁腺病灶的诊断效能[J]. 中国医学影像技术, 2018,34(4): 509-513. |
| 26 | LEMOINE S, FIGUERES L, BACCHETTA J, et al. Calcium homeostasis and hyperparathyroidism: Nephrologic and endocrinologic points of view[J]. Ann Endocrinol (Paris), 2022,83(4): 237-243. doi:10.1016/j.ando.2022.05.003 |
| 27 | 吴听潮, 周文轩, 程灵超, 等. 继发性甲状旁腺功能亢进疾病相关分子的筛选与验证[J]. 中国普通外科杂志, 2023,32(3): 400-407. |
| 28 | BROWN E M, MACLEOD R J. Extracellular calcium sensing and extracellular calcium signaling[J]. Physiol Rev, 2001,81(1): 239-297. doi:10.1152/physrev.2001.81.1.239 |
| 29 | FALCO J, DIP F, QUADRI P, et al. Cutting edge in thyroid surgery: Autofluorescence of parathyroid glands[J]. J Am Coll Surg, 2016,223(2): 374-380. doi:10.1016/j.jamcollsurg.2016.04.049 |
| 30 | De LEEUW F, BREUSKIN I, ABBACI M, et al. Intraoperative near-infrared imaging for parathyroid gland identification by auto-fluorescence: A feasibility study[J]. World J Surg, 2016,40(9): 2131-2138. doi:10.1007/s00268-016-3571-5 |
| 31 | THOMAS G, MCWADE M A, PARAS C, et al. Developing a clinical prototype to guide surgeons for intraoperative label-free identification of parathyroid glands in real time[J]. Thyroid, 2018,28(11): 1517-1531. doi:10.1089/thy.2017.0716 |
| 32 | 祝玉祥, 牟洪宾, 李春莲, 等. γ探测仪引导下甲状旁腺全切除及自体移植治疗继发性甲状旁腺功能亢进的效果[J]. 中国普外基础与临床杂志, 2022,29(7): 933-938. |
| 33 | 孙玮笛, 杨洁, 任艳鑫, 等. 免疫胶体金试纸法验证甲状旁腺的临床应用研究[J]. 中国肿瘤临床, 2019,46(23): 1206-1211. |
| 34 | THOMSEN A R, SMAJILOVIC S, BRAUNER-OSBORNE H. Novel strategies in drug discovery of the calcium-sensing receptor based on biased signaling[J]. Curr Drug Targets, 2012,13(10): 1324-1335. doi:10.2174/138945012802429642 |
| 35 | LAU W L, KALANTAR-ZADEH K, KOVESDY C P, et al. Alkaline phosphatase: better than PTH as a marker of cardiovascular and bone disease?[J]. Hemodial Int, 2014,18(4): 720-724. doi:10.1111/hdi.12190 |
| 36 | LI J, MOLNAR M Z, ZARITSKY J J, et al. Correlates of parathyroid hormone concentration in hemodialysis patients[J]. Nephrol Dial Transplant, 2013,28(6): 1516-1525. doi:10.1093/ndt/gfs598 |
| 37 | SHANTOUF R, KOVESDY C P, KIM Y, et al. Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients[J]. Clin J Am Soc Nephrol, 2009,4(6): 1106-1114. doi:10.2215/cjn.06091108 |
| 38 | GONG W, LIN Y, XIE Y, et al. Predictors of early postoperative hypocalcemia in patients with secondary hyperparathyroidism undergoing total parathyroidectomy[J]. J Int Med Res, 2021,49(5): 675891350. doi:10.1177/03000605211015018 |
| 39 | SHAN C X, QIU N C, ZHA S L, et al. A novel surgical strategy for secondary hyperparathyroidism: Purge parathyroidectomy[J]. Int J Surg, 2017,43: 112-118. doi:10.1016/j.ijsu.2017.05.062 |
/
| 〈 |
|
〉 |